Concepedia

Author

Kavya Ramkumar

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

K. R. Ramkumar, K. Ramkumar, Kavya Ramkumar, Ramkumar, Kavya, Ramkumar, Kavya (author)

135

Publications

2K

Citations

15

H-Index

27

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterUniversity of Campania "Luigi Vanvitelli"The University of Texas Southwestern Medical CenterAstraZeneca (United States)
KR

About

Kavya Ramkumar is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

1.2K

2

Immunology

4

4

1.2K

3

Natural Sciences

1

1

40

4

Biochemistry

1

1

40

5

Cell Biology

1

1

14

Kavya Ramkumar

×

16

Publications

1.7K

Citations

13

H-Index

YearCitations

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park,

Cancer Cell

2021

864

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Carminia Maria Della Corte, Triparna Sen, Carl M. Gay,

Journal of Thoracic Oncology

2020

188

Combination Treatment of the Oral CHK1 Inhibitor, SRA737, and Low-Dose Gemcitabine Enhances the Effect of Programmed Death Ligand 1 Blockade by Modulating the Immune Microenvironment in SCLC

Triparna Sen, Carminia Maria Della Corte, Snezana Milutinovic,

Journal of Thoracic Oncology

2019

118

The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer

Soma Samanta, Suhui Yang, Bikash Debnath,

Cancer Research

2021

111

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

Kasey R. Cargill, C. Allison Stewart, Elizabeth M. Park,

Cancer & Metabolism

2021

60

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

C. Allison Stewart, Carl M. Gay, Kavya Ramkumar,

Journal of Thoracic Oncology

2021

56

AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Kavya Ramkumar, C. Allison Stewart, Kasey R. Cargill,

Molecular Cancer Research

2020

52

Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase Inhibitors

Kavya Ramkumar, K. V. Tambov, Rambabu Gundla,

Bioorganic & Medicinal Chemistry

2008

40

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

C. Allison Stewart, Carl M. Gay, Kavya Ramkumar,

2020

38

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

Kiran Kundu, Robert J. Cardnell, Bingnan Zhang,

Translational Lung Cancer Research

2021

38

Page 1